NCT03964987View on ClinicalTrials.gov

Pancreatic Duodenal Homeobox Factor-1 (PDX-1) and Neurogenin-3 (NGN-3) in Gestational Diabetes

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

December 31, 2018

Conditions
Gestational Diabetes
Trial Locations (1)

50130

"Materno-Perinatal Hospital Mónica Pretelini", Toluca

All Listed Sponsors
collaborator

Universidad Autonoma del Estado de Mexico

OTHER

lead

Materno-Perinatal Hospital of the State of Mexico

OTHER

NCT03964987 - Pancreatic Duodenal Homeobox Factor-1 (PDX-1) and Neurogenin-3 (NGN-3) in Gestational Diabetes | Biotech Hunter | Biotech Hunter